Alisa M. Agne
Giessen, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Commercial α1-antitrypsin preparations markedly differ in their potential to inhibit the ATP-induced release of monocytic interleukin-1β.
Journal: Pulmonary pharmacology & therapeutics
Published: November 17, 2020
Who Is Afraid of CRP? Elevated Preoperative CRP Levels Might Attenuate the Increase in Inflammatory Parameters in Response to Lung Cancer Surgery.
Journal: Journal of clinical medicine
Published: September 29, 2020
Amyloid Beta Peptide (Aβ1-42) Reverses the Cholinergic Control of Monocytic IL-1β Release.
Journal: Journal of clinical medicine
Published: July 14, 2020
Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study.
Journal: International immunopharmacology
Published: January 07, 2020
SLPI Inhibits ATP-Mediated Maturation of IL-1β in Human Monocytic Leukocytes: A Novel Function of an Old Player.
Journal: Frontiers in immunology
Published: November 30, 2018
Alpha-1 Antitrypsin Inhibits ATP-Mediated Release of Interleukin-1β via CD36 and Nicotinic Acetylcholine Receptors.
Journal: Frontiers in immunology
Published: January 02, 2018
Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Journal: Frontiers in cellular neuroscience
Published: April 25, 2017
Hydrogen sulfide decreases β-adrenergic agonist-stimulated lung liquid clearance by inhibiting ENaC-mediated transepithelial sodium absorption.
Journal: American journal of physiology. Regulatory, integrative and comparative physiology
Published: December 01, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026